Cardeas Pharma Obtains $5,000,000 New Funding Round

  • Feed Type
  • Date
    12/20/2011
  • Company Name
    Cardeas Pharma
  • Mailing Address
    2518 Eastlake Ave. E. Seattle, WA 98102
  • Company Description
    The company is a stealth mode pharmaceutical developer.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company plans to use the money to run both preclinical experiments and initial clinical trials of a novel therapeutic to be used in hospitals.
  • M&A Terms
  • Venture Investor
    De Novo Ventures
  • Venture Investor
    Avalon Ventures
  • Venture Investor
    WRF Capital
  • Venture Investor
    Devon Park Bioventures

By posting a comment, you agree to our terms and conditions.